search
Back to results

Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD (COPD-SAFE) (COPD-SAFE)

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Not yet recruiting
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Minute volume target of 100%
Minute volume target to reach PaCO2 less than 45% (high tidal volume)
Sponsored by
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Chronic Obstructive Pulmonary Disease focused on measuring Mechanical ventilation, Adaptive Support Ventilation, Transpulmonary pressure, Intrinsic PEEP, Safety

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Acute exacerbation of Chronic Obstructive Lung Disease
  • Being intubated for less than 24 hours
  • Not being planned to be extubated in 24 hours
  • Expiratory time constant (RCexp) more than > 2.0 s

Exclusion Criteria:

  • Restrictive lung pathologies
  • Impaired hemodynamic status
  • Esophageal pathologies
  • Bronchopleural fistula

Sites / Locations

  • Izmir Dr. Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Experimental

Active Comparator

Arm Label

1.1. ASV, MV target 100%

1.2. Volume control, MV target %100

2.1. ASV, MV target to reach PaCO2< 45 mmHg

2.2. Volume control, MV target to reach PaCO2< 45 mmHg

Arm Description

Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.

Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3 Ventilation frequency will be adjusted to reach the same volume target calculated in arm1.

Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.

Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3. Ventilation frequency will be adjusted to reach the target PaCO2 level

Outcomes

Primary Outcome Measures

Transpulmonary inspiratory pressure (Ptinsp)
Ptpinsp will be measured with an inspiratory pause maneuver.

Secondary Outcome Measures

Intrinsic Positive End Expiratory Pressure (PEEPi)
PEEPi will be measured with an expiratory hold maneuver.

Full Information

First Posted
September 11, 2019
Last Updated
May 4, 2023
Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04089111
Brief Title
Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD (COPD-SAFE)
Acronym
COPD-SAFE
Official Title
Does Automatically Generated Tidal Volumes With Closed-loop Ventilation Leads to Safe Transpulmonary Pressures in Intubated Chronic Obstructive Pulmonary Disease Patients?
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
June 2023 (Anticipated)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the safety and efficacy of high tidal volumes generated by "Adapted Support Ventilation (ASV) mode' in mechanically ventilated severe COPD patients. Every patient will be ventilated consecutively with ASV and Volume Control (VC) modes at 2 different levels of minute volume in 2 sets. ASV mode is expected to be safe measured by adequate inspiratory transpulmonary pressures and expected to be as effective as VC mode with lower intrinsic positive end expiratory pressure (iPEEP) levels.
Detailed Description
Acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) may require mechanical ventilation. Various mechanical ventilation strategies and modes can be used to manage respiratory insufficiency in such patients. High tidal volumes required for mechanical ventilation of patients with obstructive pathologies is a well-known fact. Adapted Support Ventilation (ASV) is an intelligent closed-loop mechanical ventilation mode which automatically adjusts ventilation to lung mechanics. Led by measured lung mechanics, ASV mode often generates higher than usual tidal volumes during mechanical ventilation of COPD patients, particularly if the minute volume (MV) target is high. Thus, the effects of high tidal volumes on inspiratory transpulmonary pressure (Ptp), and whether Ptp stays within safe limits during ASV mode is of great interest. Patients with acute exacerbation of COPD who required mechanical ventilation will be enrolled in the first 24 hours of admission to the intensive care unit. All patients will be deeply sedated. An esophageal balloon catheter will be inserted in order to measure transpulmonary pressure. 100 % minute volume target will be calculated in advance as 100 ml per ideal body weight. Patients will be ventilated with two different MV targets in two sets. 'Adapted support ventilation' and 'volume control (VC)' modes will be used consecutively within each set. While the target minute volume will be 100 % in the first set, the volume target in the second set will be tuned to decrease patients PaCO2 below 45 mmHg. The sequence of ventilation mode will be randomized within each set. Ventilation periods will be 30 minutes with 15 minutes washout period in between. İf Ptp increase above 20 cmH20 at any ventilation mode, the tidal volume will be decreased. ASV mode is expected to be safe, assessed by adequate inspiratory transpulmonary pressures, and expected to be as effective as VC mode with lower intrinsic positive end expiratory pressure (iPEEP) levels.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
Mechanical ventilation, Adaptive Support Ventilation, Transpulmonary pressure, Intrinsic PEEP, Safety

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Patients will be ventilated for two different minute volume targets in two sets. 'Adapted support ventilation' and 'volume control (VC)' modes will be used consecutively in each set. Every patient will be ventilated 1.1. ASV with minute volume target of % 100; 1.2. VC with same MV target; 2.1 ASV with MV target associated with PaCo2 less than 45 mmHg; 2.2 VC with same MV target. Sequence of ventilation modes wıll be randomized within each group.
Masking
ParticipantOutcomes Assessor
Masking Description
Patients will not be aware of the procedure or ventilation modes that will be performed. Outcomes will be analyzed by an independent statistician.
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1.1. ASV, MV target 100%
Arm Type
Experimental
Arm Description
Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.
Arm Title
1.2. Volume control, MV target %100
Arm Type
Active Comparator
Arm Description
Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3 Ventilation frequency will be adjusted to reach the same volume target calculated in arm1.
Arm Title
2.1. ASV, MV target to reach PaCO2< 45 mmHg
Arm Type
Experimental
Arm Description
Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.
Arm Title
2.2. Volume control, MV target to reach PaCO2< 45 mmHg
Arm Type
Active Comparator
Arm Description
Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3. Ventilation frequency will be adjusted to reach the target PaCO2 level
Intervention Type
Other
Intervention Name(s)
Minute volume target of 100%
Intervention Description
Patients will be ventilated to reach minute volume target of %100 (100 ml per ideal body weight).
Intervention Type
Other
Intervention Name(s)
Minute volume target to reach PaCO2 less than 45% (high tidal volume)
Intervention Description
Patients will be ventilated to reach minute volume target associated with PaCO2 less than 45%.
Primary Outcome Measure Information:
Title
Transpulmonary inspiratory pressure (Ptinsp)
Description
Ptpinsp will be measured with an inspiratory pause maneuver.
Time Frame
30'th minute of each intervention arm
Secondary Outcome Measure Information:
Title
Intrinsic Positive End Expiratory Pressure (PEEPi)
Description
PEEPi will be measured with an expiratory hold maneuver.
Time Frame
30'th minute of each intervention arm
Other Pre-specified Outcome Measures:
Title
Mean arterial pressure
Description
Mean arterial pressure measured by invasive or non-invasive methods
Time Frame
30'th minute of each intervention arm
Title
PaO2, FiO2 ratio
Description
Ratio of arterial partial oxygen pressure to inspired fraction of oxygen
Time Frame
30'th minute of each intervention arm
Title
Heart rate
Description
Heart rate measured by ECG
Time Frame
30'th minute of each intervention arm

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acute exacerbation of Chronic Obstructive Lung Disease Being intubated for less than 24 hours Not being planned to be extubated in 24 hours Expiratory time constant (RCexp) more than > 2.0 s Exclusion Criteria: Restrictive lung pathologies Impaired hemodynamic status Esophageal pathologies Bronchopleural fistula
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sami C Kirakli, MD
Phone
+905052352024
Email
samicenk.kirakli@sbu.edu.tr
First Name & Middle Initial & Last Name or Official Title & Degree
Burcu Acar Cinleti, MD
Phone
+905075022780
Email
burcu_acar911@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sami C Kirakli, MD
Organizational Affiliation
Dr. Suat Seren Chest Diseases and Surgery Educatin and Resarch Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Izmir Dr. Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit
City
Izmir
State/Province
Yenisehir
ZIP/Postal Code
35550
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
19001507
Citation
Talmor D, Sarge T, Malhotra A, O'Donnell CR, Ritz R, Lisbon A, Novack V, Loring SH. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008 Nov 13;359(20):2095-104. doi: 10.1056/NEJMoa0708638. Epub 2008 Nov 11.
Results Reference
background
PubMed Identifier
28828360
Citation
Grieco DL, Chen L, Brochard L. Transpulmonary pressure: importance and limits. Ann Transl Med. 2017 Jul;5(14):285. doi: 10.21037/atm.2017.07.22.
Results Reference
background
PubMed Identifier
27334266
Citation
Mauri T, Yoshida T, Bellani G, Goligher EC, Carteaux G, Rittayamai N, Mojoli F, Chiumello D, Piquilloud L, Grasso S, Jubran A, Laghi F, Magder S, Pesenti A, Loring S, Gattinoni L, Talmor D, Blanch L, Amato M, Chen L, Brochard L, Mancebo J; PLeUral pressure working Group (PLUG-Acute Respiratory Failure section of the European Society of Intensive Care Medicine). Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives. Intensive Care Med. 2016 Sep;42(9):1360-73. doi: 10.1007/s00134-016-4400-x. Epub 2016 Jun 22.
Results Reference
background
PubMed Identifier
24467647
Citation
Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso S, Chiumello D, Guerin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin M, Mancebo J, Brochard L; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine). The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31. doi: 10.1164/rccm.201312-2193CI.
Results Reference
background

Learn more about this trial

Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD (COPD-SAFE)

We'll reach out to this number within 24 hrs